查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1721229

帶因者篩檢市場（類型：擴展帶因者篩檢、標靶疾病帶因者篩檢；樣本類型：血液、唾液、其他）－2025 年至 2035 年全球產業分析、規模、佔有率、成長、趨勢和預測

Carrier Screening Market (Type: Expanded Carrier Screening, Targeted Disease Carrier Screening; and Sample Type: Blood, Saliva, Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025-2035
出版日期: | 出版商: Transparency Market Research | 英文 213 Pages | 商品交期: 2-10個工作天內

價格

攜帶者篩檢市場 - 報告範圍

TMR 關於全球攜帶者篩檢市場的報告研究了過去和當前的成長趨勢和機會，以獲得 2025 年至 2035 年預測期內市場指標的寶貴見解。該報告提供了 2019 年至 2035 年期間全球帶因者篩檢市場的收入，以 2025 年為基準年，2035 年為預測年。報告中也提供了2025年至2035年全球帶因者篩檢市場的年複合成長率（CAGR%）。

該報告是經過廣泛研究後編寫的。初步研究涉及大部分研究工作，其中分析師對關鍵意見領袖、行業領導者和輿論製造者進行了訪談。二次研究涉及參考主要參與者的產品文獻、年度報告、新聞稿和相關文件，以了解承運人篩選市場。

市場概況
2024 年的市場價值 17億美元
2035年的市場價值 58億美元
複合年成長率 11.8%

該報告深入探討了全球帶因者篩檢市場的競爭格局。我們已經確定了在全球攜帶者篩檢市場中運作的關鍵參與者，並根據各種屬性對每個參與者進行了分析。公司概況、財務狀況、最新發展和 SWOT 是本報告介紹的全球攜帶者篩檢市場參與者的屬性。

目錄

第1章：前言

第2章：假設與研究方法

第3章：執行摘要：全球市場

第4章：市場概覽

  • 介紹
  • 概述
  • 市場動態
  • 2020-2035年全球帶因者篩檢市場分析與預測

第5章：關鍵見解

  • 重要產業活動
  • 波特五力分析
  • 供應鏈分析
  • 大環境分析
  • 技術進步
  • 市場未滿足的需求
  • 疾病流行病學

第6章：全球市場分析與預測：依類型

  • 介紹和定義
  • 主要發現/進展
  • 市場價值預測：按類型，2020-2035
    • 擴大攜帶者篩檢
    • 針對性疾病帶因者篩檢
  • 市場吸引力分析：按類型

第7章：全球市場分析與預測：依樣本類型

  • 介紹和定義
  • 主要發現/進展
  • 市場價值預測：依樣品類型，2020-2035
    • 血
    • 唾液
    • 其他
  • 市場吸引力分析：依樣品類型

第8章：全球市場分析與預測：依技術

  • 介紹和定義
  • 主要發現/進展
  • 市場價值預測：按技術，2020-2035
    • DNA定序
    • 聚合酶鍊式反應
    • 微陣列
    • 其他
  • 市場吸引力分析：按技術

第9章：全球市場分析與預測：按應用

  • 介紹和定義
  • 主要發現/進展
  • 市場價值預測：按應用，2020-2035
    • 囊腫纖維化
    • 泰-薩克斯病
    • 戈謝氏症
    • 鐮形血球貧血症
    • 其他
  • 市場吸引力分析：按應用

第10章：全球市場分析與預測：依最終用戶

  • 介紹和定義
  • 主要發現/進展
  • 市場價值預測：按最終用戶，2020-2035
    • 醫院和診所
    • 參考實驗室
    • 其他
  • 市場吸引力分析：按最終用戶

第 11 章：全球市場分析與預測：按地區

  • 主要發現
  • 市場價值預測：按地區，2020-2035
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 市場吸引力分析：按地區

第12章：北美市場分析與預測

第13章：歐洲市場分析與預測

第14章：亞太市場分析與預測

第15章：拉丁美洲市場分析與預測

第16章：中東與非洲市場分析與預測

第 17 章：競爭格局

  • 市場參與者 - 競爭矩陣（依公司層級和規模）
  • 市佔率分析：按公司（2024年）
  • 公司簡介
    • Myriad Genetics, Inc.
    • Cepheid
    • Illumina
    • Thermo Fisher Scientific, Inc.
    • F.Hoffmann-La Roche Ltd
    • LabCorp.
    • Otogenetics
    • MedGenome
    • GeneTech
    • Centogene NV
    • Fulgent Genetics
    • OPKO Health Inc.
    • Quest Diagnostics Incorporated
    • Natera Inc.
Product Code: TMRGL86568

Carrier Screening Market - Scope of Report

TMR's report on the global carrier screening market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2025 to 2035. The report provides revenue of the global carrier screening market for the period 2019-2035, considering 2025 as the base year and 2035 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global carrier screening market from 2025 to 2035.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the carrier screening market.

Market Snapshot
Market Value in 2024US$ 1.7 Bn
Market Value in 2035US$ 5.8 Bn
CAGR11.8%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global carrier screening market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global carrier screening market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global carrier screening market.

The report delves into the competitive landscape of the global carrier screening market. Key players operating in the global carrier screening market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global carrier screening market profiled in this report.

Key Questions Answered in Global carrier screening market Report:

  • What is the sales/revenue generated by carrier screening across all regions during the forecast period?
  • What are the opportunities in the global carrier screening market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2035?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Carrier Screening Market - Research Objectives and Research Approach

The comprehensive report on the global carrier screening market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global carrier screening market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2035 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global carrier screening market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Carrier Screening Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Carrier Screening Market Analysis and Forecast, 2020-2035
    • 4.4.1. Market Revenue Projections (US$ Bn)

5. Key Insights

  • 5.1. Key Industry Events
  • 5.2. PORTER's Five Forces Analysis
  • 5.3. Supply Chain Analysis
  • 5.4. PESTLE Analysis
  • 5.5. Technological Advancements
  • 5.6. Unmet Needs of the Market
  • 5.7. Epidemiology of Diseases

6. Global Carrier Screening Market Analysis and Forecast, by Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Type, 2020-2035
    • 6.3.1. Expanded Carrier Screening
    • 6.3.2. Targeted Disease Carrier Screening
  • 6.4. Market Attractiveness Analysis, by Type

7. Global Carrier Screening Market Analysis and Forecast, by Sample Type

  • 7.1. Introduction & Definition
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Sample Type, 2020-2035
    • 7.3.1. Blood
    • 7.3.2. Saliva
    • 7.3.3. Others
  • 7.4. Market Attractiveness Analysis, by Sample Type

8. Global Carrier Screening Market Analysis and Forecast, by Technique

  • 8.1. Introduction & Definition
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by Technique, 2020-2035
    • 8.3.1. DNA Sequencing
    • 8.3.2. Polymerase Chain Reaction
    • 8.3.3. Microarrays
    • 8.3.4. Others
  • 8.4. Market Attractiveness Analysis, by Technique

9. Global Carrier Screening Market Analysis and Forecast, by Application

  • 9.1. Introduction & Definition
  • 9.2. Key Findings/Developments
  • 9.3. Market Value Forecast, by Application, 2020-2035
    • 9.3.1. Cystic Fibrosis
    • 9.3.2. Tay-Sachs
    • 9.3.3. Gaucher Disease
    • 9.3.4. Sickle Cell Disease
    • 9.3.5. Others
  • 9.4. Market Attractiveness Analysis, by Application

10. Global Carrier Screening Market Analysis and Forecast, by End-user

  • 10.1. Introduction & Definition
  • 10.2. Key Findings/Developments
  • 10.3. Market Value Forecast, by End-user, 2020-2035
    • 10.3.1. Hospitals & Clinics
    • 10.3.2. Reference Laboratories
    • 10.3.3. Others
  • 10.4. Market Attractiveness Analysis, by End-user

11. Global Carrier Screening Market Analysis and Forecast, by Region

  • 11.1. Key Findings
  • 11.2. Market Value Forecast, by Region, 2020-2035
    • 11.2.1. North America
    • 11.2.2. Europe
    • 11.2.3. Asia Pacific
    • 11.2.4. Latin America
    • 11.2.5. Middle East & Africa
  • 11.3. Market Attractiveness Analysis, by Region

12. North America Carrier Screening Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Type, 2020-2035
    • 12.2.1. Expanded Carrier Screening
    • 12.2.2. Targeted Disease Carrier Screening
  • 12.3. Market Value Forecast, by Sample Type, 2020-2035
    • 12.3.1. Blood
    • 12.3.2. Saliva
    • 12.3.3. Others
  • 12.4. Market Value Forecast, by Technique, 2020-2035
    • 12.4.1. DNA Sequencing
    • 12.4.2. Polymerase Chain Reaction
    • 12.4.3. Microarrays
    • 12.4.4. Others
  • 12.5. Market Value Forecast, by Application, 2020-2035
    • 12.5.1. Cystic Fibrosis
    • 12.5.2. Tay-Sachs
    • 12.5.3. Gaucher Disease
    • 12.5.4. Sickle Cell Disease
    • 12.5.5. Others
  • 12.6. Market Value Forecast, by End-user, 2020-2035
    • 12.6.1. Hospitals & Clinics
    • 12.6.2. Reference Laboratories
    • 12.6.3. Others
  • 12.7. Market Value Forecast, by Country, 2020-2035
    • 12.7.1. U.S.
    • 12.7.2. Canada
  • 12.8. Market Attractiveness Analysis
    • 12.8.1. By Type
    • 12.8.2. By Sample Type
    • 12.8.3. By Technique
    • 12.8.4. By Application
    • 12.8.5. By End-user
    • 12.8.6. By Country

13. Europe Carrier Screening Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Type, 2020-2035
    • 13.2.1. Expanded Carrier Screening
    • 13.2.2. Targeted Disease Carrier Screening
  • 13.3. Market Value Forecast, by Sample Type, 2020-2035
    • 13.3.1. Blood
    • 13.3.2. Saliva
    • 13.3.3. Others
  • 13.4. Market Value Forecast, by Technique, 2020-2035
    • 13.4.1. DNA Sequencing
    • 13.4.2. Polymerase Chain Reaction
    • 13.4.3. Microarrays
    • 13.4.4. Others
  • 13.5. Market Value Forecast, by Application, 2020-2035
    • 13.5.1. Cystic Fibrosis
    • 13.5.2. Tay-Sachs
    • 13.5.3. Gaucher Disease
    • 13.5.4. Sickle Cell Disease
    • 13.5.5. Others
  • 13.6. Market Value Forecast, by End-user, 2020-2035
    • 13.6.1. Hospitals & Clinics
    • 13.6.2. Reference Laboratories
    • 13.6.3. Others
  • 13.7. Market Value Forecast, by Country/Sub-region, 2020-2035
    • 13.7.1. Germany
    • 13.7.2. UK
    • 13.7.3. France
    • 13.7.4. Italy
    • 13.7.5. Spain
    • 13.7.6. Rest of Europe
  • 13.8. Market Attractiveness Analysis
    • 13.8.1. By Type
    • 13.8.2. By Sample Type
    • 13.8.3. By Technique
    • 13.8.4. By Application
    • 13.8.5. By End-user
    • 13.8.6. By Country/Sub-region

14. Asia Pacific Carrier Screening Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Type, 2020-2035
    • 14.2.1. Expanded Carrier Screening
    • 14.2.2. Targeted Disease Carrier Screening
  • 14.3. Market Value Forecast, by Sample Type, 2020-2035
    • 14.3.1. Blood
    • 14.3.2. Saliva
    • 14.3.3. Others
  • 14.4. Market Value Forecast, by Technique, 2020-2035
    • 14.4.1. DNA Sequencing
    • 14.4.2. Polymerase Chain Reaction
    • 14.4.3. Microarrays
    • 14.4.4. Others
  • 14.5. Market Value Forecast, by Application, 2020-2035
    • 14.5.1. Cystic Fibrosis
    • 14.5.2. Tay-Sachs
    • 14.5.3. Gaucher Disease
    • 14.5.4. Sickle Cell Disease
    • 14.5.5. Others
  • 14.6. Market Value Forecast, by End-user, 2020-2035
    • 14.6.1. Hospitals & Clinics
    • 14.6.2. Reference Laboratories
    • 14.6.3. Others
  • 14.7. Market Value Forecast, by Country/Sub-region, 2020-2035
    • 14.7.1. China
    • 14.7.2. Japan
    • 14.7.3. India
    • 14.7.4. Australia & New Zealand
    • 14.7.5. Rest of Asia Pacific
  • 14.8. Market Attractiveness Analysis
    • 14.8.1. By Type
    • 14.8.2. By Sample Type
    • 14.8.3. By Technique
    • 14.8.4. By Application
    • 14.8.5. By End-user
    • 14.8.6. By Country/Sub-region

15. Latin America Carrier Screening Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast, by Type, 2020-2035
    • 15.2.1. Expanded Carrier Screening
    • 15.2.2. Targeted Disease Carrier Screening
  • 15.3. Market Value Forecast, by Sample Type, 2020-2035
    • 15.3.1. Blood
    • 15.3.2. Saliva
    • 15.3.3. Others
  • 15.4. Market Value Forecast, by Technique, 2020-2035
    • 15.4.1. DNA Sequencing
    • 15.4.2. Polymerase Chain Reaction
    • 15.4.3. Microarrays
    • 15.4.4. Others
  • 15.5. Market Value Forecast, by Application, 2020-2035
    • 15.5.1. Cystic Fibrosis
    • 15.5.2. Tay-Sachs
    • 15.5.3. Gaucher Disease
    • 15.5.4. Sickle Cell Disease
    • 15.5.5. Others
  • 15.6. Market Value Forecast, by End-user, 2020-2035
    • 15.6.1. Hospitals & Clinics
    • 15.6.2. Reference Laboratories
    • 15.6.3. Others
  • 15.7. Market Value Forecast, by Country/Sub-region, 2020-2035
    • 15.7.1. Brazil
    • 15.7.2. Mexico
    • 15.7.3. Rest of Latin America
  • 15.8. Market Attractiveness Analysis
    • 15.8.1. By Type
    • 15.8.2. By Sample Type
    • 15.8.3. By Technique
    • 15.8.4. By Application
    • 15.8.5. By End-user
    • 15.8.6. By Country/Sub-region

16. Middle East & Africa Carrier Screening Market Analysis and Forecast

  • 16.1. Introduction
    • 16.1.1. Key Findings
  • 16.2. Market Value Forecast, by Type, 2020-2035
    • 16.2.1. Expanded Carrier Screening
    • 16.2.2. Targeted Disease Carrier Screening
  • 16.3. Market Value Forecast, by Sample Type, 2020-2035
    • 16.3.1. Blood
    • 16.3.2. Saliva
    • 16.3.3. Others
  • 16.4. Market Value Forecast, by Technique, 2020-2035
    • 16.4.1. DNA Sequencing
    • 16.4.2. Polymerase Chain Reaction
    • 16.4.3. Microarrays
    • 16.4.4. Others
  • 16.5. Market Value Forecast, by Application, 2020-2035
    • 16.5.1. Cystic Fibrosis
    • 16.5.2. Tay-Sachs
    • 16.5.3. Gaucher Disease
    • 16.5.4. Sickle Cell Disease
    • 16.5.5. Others
  • 16.6. Market Value Forecast, by End-user, 2020-2035
    • 16.6.1. Hospitals & Clinics
    • 16.6.2. Reference Laboratories
    • 16.6.3. Others
  • 16.7. Market Value Forecast, by Country/Sub-region, 2020-2035
    • 16.7.1. GCC Countries
    • 16.7.2. South Africa
    • 16.7.3. Rest of Middle East & Africa
  • 16.8. Market Attractiveness Analysis
    • 16.8.1. By Type
    • 16.8.2. By Sample Type
    • 16.8.3. By Technique
    • 16.8.4. By Application
    • 16.8.5. By End-user
    • 16.8.6. By Country/Sub-region

17. Competition Landscape

  • 17.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 17.2. Market Share Analysis, by Company (2024)
  • 17.3. Company Profiles
    • 17.3.1. Myriad Genetics, Inc.
      • 17.3.1.1. Company Overview
      • 17.3.1.2. Financial Overview
      • 17.3.1.3. Product Portfolio
      • 17.3.1.4. Business Strategies
      • 17.3.1.5. Recent Developments
    • 17.3.2. Cepheid
      • 17.3.2.1. Company Overview
      • 17.3.2.2. Financial Overview
      • 17.3.2.3. Product Portfolio
      • 17.3.2.4. Business Strategies
      • 17.3.2.5. Recent Developments
    • 17.3.3. Illumina
      • 17.3.3.1. Company Overview
      • 17.3.3.2. Financial Overview
      • 17.3.3.3. Product Portfolio
      • 17.3.3.4. Business Strategies
      • 17.3.3.5. Recent Developments
    • 17.3.4. Thermo Fisher Scientific, Inc.
      • 17.3.4.1. Company Overview
      • 17.3.4.2. Financial Overview
      • 17.3.4.3. Product Portfolio
      • 17.3.4.4. Business Strategies
      • 17.3.4.5. Recent Developments
    • 17.3.5. F.Hoffmann-La Roche Ltd
      • 17.3.5.1. Company Overview
      • 17.3.5.2. Financial Overview
      • 17.3.5.3. Product Portfolio
      • 17.3.5.4. Business Strategies
      • 17.3.5.5. Recent Developments
    • 17.3.6. LabCorp.
      • 17.3.6.1. Company Overview
      • 17.3.6.2. Financial Overview
      • 17.3.6.3. Product Portfolio
      • 17.3.6.4. Business Strategies
      • 17.3.6.5. Recent Developments
    • 17.3.7. Otogenetics
      • 17.3.7.1. Company Overview
      • 17.3.7.2. Financial Overview
      • 17.3.7.3. Product Portfolio
      • 17.3.7.4. Business Strategies
      • 17.3.7.5. Recent Developments
    • 17.3.8. MedGenome
      • 17.3.8.1. Company Overview
      • 17.3.8.2. Financial Overview
      • 17.3.8.3. Product Portfolio
      • 17.3.8.4. Business Strategies
      • 17.3.8.5. Recent Developments
    • 17.3.9. GeneTech
      • 17.3.9.1. Company Overview
      • 17.3.9.2. Financial Overview
      • 17.3.9.3. Product Portfolio
      • 17.3.9.4. Business Strategies
      • 17.3.9.5. Recent Developments
    • 17.3.10. Centogene N.V.
      • 17.3.10.1. Company Overview
      • 17.3.10.2. Financial Overview
      • 17.3.10.3. Product Portfolio
      • 17.3.10.4. Business Strategies
      • 17.3.10.5. Recent Developments
    • 17.3.11. Fulgent Genetics
      • 17.3.11.1. Company Overview
      • 17.3.11.2. Financial Overview
      • 17.3.11.3. Product Portfolio
      • 17.3.11.4. Business Strategies
      • 17.3.11.5. Recent Developments
    • 17.3.12. OPKO Health Inc.
      • 17.3.12.1. Company Overview
      • 17.3.12.2. Financial Overview
      • 17.3.12.3. Product Portfolio
      • 17.3.12.4. Business Strategies
      • 17.3.12.5. Recent Developments
    • 17.3.13. Quest Diagnostics Incorporated
      • 17.3.13.1. Company Overview
      • 17.3.13.2. Financial Overview
      • 17.3.13.3. Product Portfolio
      • 17.3.13.4. Business Strategies
      • 17.3.13.5. Recent Developments
    • 17.3.14. Natera Inc.
      • 17.3.14.1. Company Overview
      • 17.3.14.2. Financial Overview
      • 17.3.14.3. Product Portfolio
      • 17.3.14.4. Business Strategies
      • 17.3.14.5. Recent Developments

List of Tables

  • Table 01: Global Carrier Screening Market Value (US$ Bn) Forecast, By Type, 2020-2035
  • Table 02: Global Carrier Screening Market Value (US$ Bn) Forecast, By Sample Type, 2020-2035
  • Table 03: Global Carrier Screening Market Value (US$ Bn) Forecast, By Technique, 2020-2035
  • Table 04: Global Carrier Screening Market Value (US$ Bn) Forecast, By Application, 2020-2035
  • Table 05: Global Carrier Screening Market Value (US$ Bn) Forecast, By End-user, 2020-2035
  • Table 06: Global Carrier Screening Market Value (US$ Bn) Forecast, By Region, 2020-2035
  • Table 07: North America Carrier Screening Market Value (US$ Bn) Forecast, by Country, 2020-2035
  • Table 08: North America Carrier Screening Market Value (US$ Bn) Forecast, By Type, 2020-2035
  • Table 09: North America Carrier Screening Market Value (US$ Bn) Forecast, By Sample Type, 2020-2035
  • Table 10: North America Carrier Screening Market Value (US$ Bn) Forecast, By Technique, 2020-2035
  • Table 11: North America Carrier Screening Market Value (US$ Bn) Forecast, By Application, 2020-2035
  • Table 12: North America Carrier Screening Market Value (US$ Bn) Forecast, By End-user, 2020-2035
  • Table 13: Europe Carrier Screening Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020-2035
  • Table 14: Europe Carrier Screening Market Value (US$ Bn) Forecast, By Type, 2020-2035
  • Table 15: Europe Carrier Screening Market Value (US$ Bn) Forecast, By Sample Type, 2020-2035
  • Table 16: Europe Carrier Screening Market Value (US$ Bn) Forecast, By Technique, 2020-2035
  • Table 17: Europe Carrier Screening Market Value (US$ Bn) Forecast, By Application, 2020-2035
  • Table 18: Europe Carrier Screening Market Value (US$ Bn) Forecast, By End-user, 2020-2035
  • Table 19: Asia Pacific Carrier Screening Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020-2035
  • Table 20: Asia Pacific Carrier Screening Market Value (US$ Bn) Forecast, By Type, 2020-2035
  • Table 21: Asia Pacific Carrier Screening Market Value (US$ Bn) Forecast, By Sample Type, 2020-2035
  • Table 22: Asia Pacific Carrier Screening Market Value (US$ Bn) Forecast, By Technique, 2020-2035
  • Table 23: Asia Pacific Carrier Screening Market Value (US$ Bn) Forecast, By Application, 2020-2035
  • Table 24: Asia Pacific Carrier Screening Market Value (US$ Bn) Forecast, By End-user, 2020-2035
  • Table 25: Latin America Carrier Screening Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020-2035
  • Table 26: Latin America Carrier Screening Market Value (US$ Bn) Forecast, By Type, 2020-2035
  • Table 27: Latin America Carrier Screening Market Value (US$ Bn) Forecast, By Sample Type, 2020-2035
  • Table 28: Latin America Carrier Screening Market Value (US$ Bn) Forecast, By Technique, 2020-2035
  • Table 29: Latin America Carrier Screening Market Value (US$ Bn) Forecast, By Application, 2020-2035
  • Table 30: Latin America Carrier Screening Market Value (US$ Bn) Forecast, By End-user, 2020-2035
  • Table 31: Middle East & Africa Carrier Screening Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020-2035
  • Table 32: Middle East and Africa Carrier Screening Market Value (US$ Bn) Forecast, By Type, 2020-2035
  • Table 33: Middle East and Africa Carrier Screening Market Value (US$ Bn) Forecast, By Sample Type, 2020-2035
  • Table 34: Middle East and Africa Carrier Screening Market Value (US$ Bn) Forecast, By Technique, 2020-2035
  • Table 35: Middle East and Africa Carrier Screening Market Value (US$ Bn) Forecast, By Application, 2020-2035
  • Table 36: Middle East and Africa Carrier Screening Market Value (US$ Bn) Forecast, By End-user, 2020-2035

List of Figures

  • Figure 01: Global Carrier Screening Market Value Share Analysis, By Type, 2024 and 2035
  • Figure 02: Global Carrier Screening Market Attractiveness Analysis, By Type, 2025-2035
  • Figure 03: Global Carrier Screening Market Revenue (US$ Mn), by Expanded Carrier Screening, 2020-2035
  • Figure 04: Global Carrier Screening Market Revenue (US$ Mn), by Targeted Disease Carrier Screening, 2020-2035
  • Figure 05: Global Carrier Screening Market Value Share Analysis, By Sample Type, 2024 and 2035
  • Figure 06: Global Carrier Screening Market Attractiveness Analysis, By Sample Type, 2025-2035
  • Figure 07: Global Carrier Screening Market Revenue (US$ Mn), by Blood, 2020-2035
  • Figure 08: Global Carrier Screening Market Revenue (US$ Mn), by Saliva, 2020-2035
  • Figure 09: Global Carrier Screening Market Revenue (US$ Mn), by Others, 2020-2035
  • Figure 10: Global Carrier Screening Market Value Share Analysis, By Technique, 2024 and 2035
  • Figure 11: Global Carrier Screening Market Attractiveness Analysis, By Technique, 2025-2035
  • Figure 12: Global Carrier Screening Market Revenue (US$ Mn), by DNA Sequencing, 2020-2035
  • Figure 13: Global Carrier Screening Market Revenue (US$ Mn), by Polymerase Chain Reaction, 2020-2035
  • Figure 14: Global Carrier Screening Market Revenue (US$ Mn), by Microarrays, 2020-2035
  • Figure 15: Global Carrier Screening Market Revenue (US$ Mn), by Others, 2020-2035
  • Figure 16: Global Carrier Screening Market Value Share Analysis, By Application, 2024 and 2035
  • Figure 17: Global Carrier Screening Market Attractiveness Analysis, By Application, 2025-2035
  • Figure 18: Global Carrier Screening Market Revenue (US$ Mn), by Cystic Fibrosis, 2020-2035
  • Figure 19: Global Carrier Screening Market Revenue (US$ Mn), by Tay-Sachs, 2020-2035
  • Figure 20: Global Carrier Screening Market Revenue (US$ Mn), by Gaucher Disease, 2020-2035
  • Figure 21: Global Carrier Screening Market Revenue (US$ Mn), by Sickle Cell Disease, 2020-2035
  • Figure 22: Global Carrier Screening Market Revenue (US$ Mn), by Others, 2020-2035
  • Figure 23: Global Carrier Screening Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 24: Global Carrier Screening Market Attractiveness Analysis, By End-user, 2025-2035
  • Figure 25: Global Carrier Screening Market Revenue (US$ Mn), by Hospitals & Clinics, 2020-2035
  • Figure 26: Global Carrier Screening Market Revenue (US$ Mn), by Reference Laboratories, 2020-2035
  • Figure 27: Global Carrier Screening Market Revenue (US$ Mn), by Others, 2020-2035
  • Figure 28: Global Carrier Screening Market Value Share Analysis, By Region, 2024 and 2035
  • Figure 29: Global Carrier Screening Market Attractiveness Analysis, By Region, 2025-2035
  • Figure 30: North America Carrier Screening Market Value (US$ Mn) Forecast, 2020-2035
  • Figure 31: North America Carrier Screening Market Value Share Analysis, by Country, 2024 and 2035
  • Figure 32: North America Carrier Screening Market Attractiveness Analysis, by Country, 2025-2035
  • Figure 33: North America Carrier Screening Market Value Share Analysis, By Type, 2024 and 2035
  • Figure 34: North America Carrier Screening Market Attractiveness Analysis, By Type, 2025-2035
  • Figure 35: North America Carrier Screening Market Value Share Analysis, By Sample Type, 2024 and 2035
  • Figure 36: North America Carrier Screening Market Attractiveness Analysis, By Sample Type, 2025-2035
  • Figure 37: North America Carrier Screening Market Value Share Analysis, By Technique, 2024 and 2035
  • Figure 38: North America Carrier Screening Market Attractiveness Analysis, By Technique, 2025-2035
  • Figure 39: North America Carrier Screening Market Value Share Analysis, By Application, 2024 and 2035
  • Figure 40: North America Carrier Screening Market Attractiveness Analysis, By Application, 2025-2035
  • Figure 41: North America Carrier Screening Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 42: North America Carrier Screening Market Attractiveness Analysis, By End-user, 2025-2035
  • Figure 43: Europe Carrier Screening Market Value (US$ Mn) Forecast, 2020-2035
  • Figure 44: Europe Carrier Screening Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
  • Figure 45: Europe Carrier Screening Market Attractiveness Analysis, by Country / Sub-region, 2025-2035
  • Figure 46: Europe Carrier Screening Market Value Share Analysis, By Type, 2024 and 2035
  • Figure 47: Europe Carrier Screening Market Attractiveness Analysis, By Type, 2025-2035
  • Figure 48: Europe Carrier Screening Market Value Share Analysis, By Sample Type, 2024 and 2035
  • Figure 49: Europe Carrier Screening Market Attractiveness Analysis, By Sample Type, 2025-2035
  • Figure 50: Europe Carrier Screening Market Value Share Analysis, By Technique, 2024 and 2035
  • Figure 51: Europe Carrier Screening Market Attractiveness Analysis, By Technique, 2025-2035
  • Figure 52: Europe Carrier Screening Market Value Share Analysis, By Application, 2024 and 2035
  • Figure 53: Europe Carrier Screening Market Attractiveness Analysis, By Application, 2025-2035
  • Figure 54: Europe Carrier Screening Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 55: Europe Carrier Screening Market Attractiveness Analysis, By End-user, 2025-2035
  • Figure 56: Asia Pacific Carrier Screening Market Value (US$ Mn) Forecast, 2020-2035
  • Figure 57: Asia Pacific Carrier Screening Market Value Share Analysis, by Country/Sub-region, 2024 and 2035
  • Figure 58: Asia Pacific Carrier Screening Market Attractiveness Analysis, by Country/Sub-region, 2025-2035
  • Figure 59: Asia Pacific Carrier Screening Market Value Share Analysis, By Type, 2024 and 2035
  • Figure 60: Asia Pacific Carrier Screening Market Attractiveness Analysis, By Type, 2025-2035
  • Figure 61: Asia Pacific Carrier Screening Market Value Share Analysis, By Sample Type, 2024 and 2035
  • Figure 62: Asia Pacific Carrier Screening Market Attractiveness Analysis, By Sample Type, 2025-2035
  • Figure 63: Asia Pacific Carrier Screening Market Value Share Analysis, By Technique, 2024 and 2035
  • Figure 64: Asia Pacific Carrier Screening Market Attractiveness Analysis, By Technique, 2025-2035
  • Figure 65: Asia Pacific Carrier Screening Market Value Share Analysis, By Application, 2024 and 2035
  • Figure 66: Asia Pacific Carrier Screening Market Attractiveness Analysis, By Application, 2025-2035
  • Figure 67: Asia Pacific Carrier Screening Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 68: Asia Pacific Carrier Screening Market Attractiveness Analysis, By End-user, 2025-2035
  • Figure 69: Latin America Carrier Screening Market Value (US$ Mn) Forecast, 2020-2035
  • Figure 70: Latin America Carrier Screening Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
  • Figure 71: Latin America Carrier Screening Market Attractiveness Analysis, by Country / Sub-region, 2025-2035
  • Figure 72: Latin America Carrier Screening Market Value Share Analysis, By Type, 2024 and 2035
  • Figure 73: Latin America Carrier Screening Market Attractiveness Analysis, By Type, 2025-2035
  • Figure 74: Latin America Carrier Screening Market Value Share Analysis, By Sample Type, 2024 and 2035
  • Figure 75: Latin America Carrier Screening Market Attractiveness Analysis, By Sample Type, 2025-2035
  • Figure 76: Latin America Carrier Screening Market Value Share Analysis, By Technique, 2024 and 2035
  • Figure 77: Latin America Carrier Screening Market Attractiveness Analysis, By Technique, 2025-2035
  • Figure 78: Latin America Carrier Screening Market Value Share Analysis, By Application, 2024 and 2035
  • Figure 79: Latin America Carrier Screening Market Attractiveness Analysis, By Application, 2025-2035
  • Figure 80: Latin America Carrier Screening Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 81: Latin America Carrier Screening Market Attractiveness Analysis, By End-user, 2025-2035
  • Figure 82: Middle East & Africa Carrier Screening Market Value (US$ Mn) Forecast, 2020-2035
  • Figure 83: Middle East & Africa Carrier Screening Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
  • Figure 84: Middle East & Africa Carrier Screening Market Attractiveness Analysis, by Country / Sub-region, 2025-2035
  • Figure 85: Middle East and Africa Carrier Screening Market Value Share Analysis, By Type, 2024 and 2035
  • Figure 86: Middle East and Africa Carrier Screening Market Attractiveness Analysis, By Type, 2025-2035
  • Figure 87: Middle East and Africa Carrier Screening Market Value Share Analysis, By Sample Type, 2024 and 2035
  • Figure 88: Middle East and Africa Carrier Screening Market Attractiveness Analysis, By Sample Type, 2025-2035
  • Figure 89: Middle East and Africa Carrier Screening Market Value Share Analysis, By Technique, 2024 and 2035
  • Figure 90: Middle East and Africa Carrier Screening Market Attractiveness Analysis, By Technique, 2025-2035
  • Figure 91: Middle East and Africa Carrier Screening Market Value Share Analysis, By Application, 2024 and 2035
  • Figure 92: Middle East and Africa Carrier Screening Market Attractiveness Analysis, By Application, 2025-2035
  • Figure 93: Middle East and Africa Carrier Screening Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 94: Middle East and Africa Carrier Screening Market Attractiveness Analysis, By End-user, 2025-2035